U.S. Impel NeuroPharma closes Series D financing round at $67.5 mln

01/26/2019 9:35:00 AM (GMT)

U.S. medical device company Impel NeuroPharma has completed a $67.5 million Series D financing round.

Impel NeuroPharma intends to use the proceeds to accelerate the clinical development of its existing portfolio for central nervous system disorders.

The round was co-led by KKR and Northwest Venture Partners with participation from existing backers Vivo Capital, 5AM Ventures and venBio Partners.

Impel NeuroPharma has raised a total of $108.1 million in over 8 funding rounds.

Impel NeuroPharma Inc.

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text